Omnichannel has reached its limit: Why marketers should invest in optichannel instead

Omnichannel marketing has reached a point of diminishing returns. Rather than focusing on expanding the number of customer touchpoints, healthcare marketers should shift their attention toward orchestrating meaningful, relevant experiences that align with customer needs and business outcomes. In a recent MM+M article, we challenge the assumption that more channels automatically lead to greater engagement. Instead of channel volume, we firmly believe that success depends on data intelligence, personalization, and strategic execution.

As customer expectations evolve and digital interactions become more sophisticated, organizations need to rethink how they measure marketing effectiveness. The emphasis moves from simply being present across every platform to creating connected experiences that deliver value at the right moment. For pharmaceutical and healthcare brands, this means investing in optichannel engagement strategies that prioritize quality over quantity in an increasingly competitive environment.